Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies-Reference-Cited by-同舟云学术

Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies

Published:2019-02-08 Issue:3 Volume:2 Page:257-267
ISSN:2574-9870
Container-title:Journal of the American College of Clinical Pharmacy
language:en
Short-container-title:J Am Coll Clin Pharm

Author:

Hammond Drayton A.¹^ORCID,Rech Megan A.²^ORCID,Daley Mitchell J.³,Devlin John W.⁴^ORCID,Hodge Emily K.³,Kooda Kirstin J.⁵,Lat Ishaq⁶^ORCID,Personett Heather A.⁵,Roberts Russel⁷,Sacha Gretchen⁸^ORCID,Stollings Joanna L.⁹,Swanson Joseph M.¹⁰,Bauer Seth R.⁸^ORCID

Affiliation:

1. Department of Pharmacy; Rush University Medical Center; Chicago Illinois

2. Department of Pharmacy; Loyola University Medical Center; Maywood Illinois

3. Department of Pharmacy; Dell Seton Medical Center at The University of Texas; Austin Texas

4. Department of Pharmacy Practice; College of Pharmacy, Northeastern University; Boston Massachusetts

5. Department of Pharmacy; Mayo Clinic; Rochester Minnesota

6. Department of Pharmacy; Shirley Ryan AbilityLab; Chicago Illinois

7. Department of Pharmacy; Massachusetts General Hospital; Boston Massachusetts

8. Department of Pharmacy; Cleveland Clinic; Cleveland Ohio

9. Department of Pharmaceutical Services; Vanderbilt University Medical Center; Nashville Tennessee

10. Department of Pharmacy Practice; University of Tennessee College of Pharmacy; Memphis Tennessee

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jac5.1079/fullpdf

Reference36 articles.

1. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016;Rhodes;Intensive Care Med,2017

2. Association between US norepinephrine shortage and mortality among patients with septic shock;Vail;JAMA,2017

3. ATHOS-3 investigators: angiotensin II for the treatment of vasodilatory shock;Khanna;N Engl J Med,2017

4. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204485Orig1s000SumR.pdf

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs and Resources Must Impact Clinical Decision-Making in the ICU: The Case of Vasopressor Use;Critical Care Medicine;2024-07-01

2. Vasopressin in Sepsis and Other Shock States: State of the Art;Journal of Personalized Medicine;2023-10-29

3. Optimizing Vasopressin Use and Initiation Timing in Septic Shock;CHEST;2023-07

4. Adjusting vasopressin availability and formulation: A cost-savings initiative;American Journal of Health-System Pharmacy;2022-05-23

5. Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock;Critical Care Medicine;2021-10-04